In animals injected with human ERα-negative breast cancer cells, pretreated with adiponectin, authors observed a reduction of tumor volume, whereas in the animals receiving human ERα-positive cells, authors observed an increase of tumor growth. This evidence concerns the gene ADIPOQ and breast cancer.